PIN 50 and PIN 100 treated groups notably had reduced levels of TNF-α (P<0.01, P<0.001, respectively) and IL-6 (P<0.001) and increased IL-10 (P<0.01, P<0.001, respectively) level as compared to the ISO group. The gene discussed is IL10; the disease is prostate intraepithelial neoplasia.